ACM
CYTH

AIGH Capital Management’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

AIGH Capital Management’s Portfolio CYTH Stock Details CYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-350,000
Closed -$2.36M – 63
2021
Q3 		$2.36M Buy
+350,000
New +$2.74M 0.5% 38

Other funds holding CYTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

AIGH Capital Management's CYTH Position: Q2 2021 in Review

AIGH Capital Management sold out of Cyclo Therapeutics, Inc. Common Stock (CYTH) in Q2 2021, closing a stake of 17,235 shares — an estimated $141K sold.

AIGH Capital Management first reported a position in CYTH in Q4 2020 and held it in 2 quarters. The position peaked at $1.52M in Q4 2020. 12 funds tracked by Wall St. Rank hold CYTH as of Q2 2021.

  • AIGH Capital Management reported no remaining Cyclo Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • AIGH Capital Management sold 17,235 Cyclo Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $141K.
  • AIGH Capital Management first reported a position in Cyclo Therapeutics, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • AIGH Capital Management's Cyclo Therapeutics, Inc. Common Stock position peaked at $1.52M in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Common Stock as of Q2 2021.

Based on AIGH Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.